Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 158

recruiting
3 970
countries
28
conditions
2 124

10 522 trials match your criteria

Sepsis

Recruiting

Study on Meropenem Dosing for Patients with Serious Infections in Intensive Care

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid

Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carvedilol

Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab

Study on Early Use of Ivabradine for Children with Heart Failure Due to Dilated Cardiomyopathy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Ivabradine Hydrochloride

Insomnia

Recruiting

Study on Daridorexant's Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Daridorexant

Study on Indapamide for Patients with Chronic Post-Surgical Hypoparathyroidism

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Indapamide hemihydrate

Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING COL7A1 CDNA

Study on the Safety and Effectiveness of ARI0002h and Drug Combination for Newly Diagnosed Primary Plasma Cell Leukemia Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide

A study of ruxolitinib as first treatment for children with haemophagocytic lymphohistiocytosis (HLH)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Ruxolitinib

Asthma

Recruiting

Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab

Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Estradiol

Study on Preventing Atrial Fibrillation After Heart Surgery Using Landiolol Hydrochloride in Patients with Normal Heart Function

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Landiolol Hydrochloride
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.